OpenAI on Monday said it's releasing an improved version of its GPT‑5.5‑Cyber model to trusted defenders as part of the Daybreak initiative the artificial intelligence (AI) company announced last ...

The rise of vibe coding can further amplify these problems as more operational context, architectural decisions, and business knowledge become scattered across prompts, conversations, generated code, ...

The FDIC's recent analysis of the deposit flight that helped take down Silicon Valley, Signature and First Republic banks is informative, but leaves some important questions unanswered, writes Brian ...

Combined company serves more than 100,000 data teams globally and launches its first joint product innovations for the agentic era Together, Fivetran + dbt Labs support a global community of more than ...

Fast-moving fire in Utah, the largest in the US, spreads overnight, leading to more evacuations Trump spent nearly $700K in parks money from taxpayers to fix walkway The contrarian view for Fed rate ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Coffee found to have startling effect on aging, says new study I was 6 when my father decided we'd sail around the world. I would be trapped on that boat for nearly a decade. Watch what happens when 5 ...

An experimental Intellia Therapeutics medicine that uses CRISPR technology to edit genes inside patients led to a significant reduction in attacks from a rare inherited swelling disorder after just a ...

SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE)-- Siren Biotechnology today announced the publication of its first peer-reviewed manuscript in Molecular Therapy Oncology, alongside upcoming ...

The idea is to have one central reference for all our Python dependencies, DBT being one of them. UV makes this possible because it allows us to manage Python packages via a central lock file (uv.lock ...

LONDON, April 12 (Reuters) - British drugmaker GSK's (GSK.L), opens new tab experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after ...